Centralized or decentralized manufacturing? Key business model considerations for cell therapies (RiHN Feasibility Study 1) (2016)
Attributed to:
RDM Healthcare Research Network
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 2
Parent Publication: Cell and Gene Therapy Insights
Issue: 1